Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Victoza (liraglutide) and Ozempic (semaglutide) are both GLP-1 receptor agonists used to treat Type 2 diabetes and lower the risk of heart-related problems in adults with Type 2 diabetes and heart disease. However, they have some differences. Victoza is injected once daily, while Ozempic is injected once a week, so Ozempic may be more convenient for some people. Victoza is approved for use in people aged 10 and older, whereas Ozempic is only for adults. Both medications can cause side effects like nausea, vomiting, and diarrhea, but Ozempic may also lead to "Ozempic face," a term for facial changes due to weight loss. Additionally, while neither is FDA-approved for weight loss, both can lead to weight loss as a side effect. Both come as prefilled pens, but you'll need to buy needles separately with Victoza, whereas Ozempic comes with needles. Both medications have similar warnings, such as the risk of thyroid cancer and pancreatitis. Ozempic may also cause eye problems, including diabetic retinopathy.
Victoza (liraglutide)
Ozempic (semaglutide)
Victoza (liraglutide)
Ozempic (semaglutide)
Summary of Victoza vs. Ozempic
Summary for GLP-1 agonist
Prescription only
Victoza (liraglutide) is a medication that's injected once a day. It helps lower blood sugar levels in people 10 years and older with Type 2 diabetes when used with a nutritious diet and regular exercise. It can also help lower the risk of heart-related problems in adults with Type 2 diabetes and heart disease. Victoza (liraglutide) belongs to the drug class called GLP-1 agonists. The medication comes as single-dose prefilled pens and is injected under the skin. It can cause side effects like nausea, vomiting, diarrhea, and constipation. Victoza (liraglutide) is available as both a brand-name and generic medication.
Summary for GLP-1 agonist
Prescription only
Ozempic (semaglutide) is a GLP-1 agonist used with diet and exercise to help adults manage Type 2 diabetes. It can also lower the risk of heart attack, stroke, and heart-related death in some people with Type 2 diabetes. It comes as a once-weekly injection under the skin and as a tablet taken by mouth once a day. The injection is also approved to help slow worsening kidney problems in people with Type 2 diabetes and chronic kidney disease (CKD). Common side effects include nausea, vomiting, and diarrhea.
Indications of Victoza vs. Ozempic
Indications for
•Type 2 diabetes in people age 10 and older, together with a balanced diet and exercise
•Lowering the risk of serious heart-related problems in adults with Type 2 diabetes and heart disease